Mocravimod not checked

Priothera SAS · KRP-203

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
2 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Adult Acute Myeloid Leukemia
Main trialPhase 3
“This is a multi-center, randomized, double-blinded, placebo controlled trial.”In the company’s words, NCT05429632 on ClinicalTrials.gov
Other names
KRP-203

Other drugs for Adult Acute Myeloid Leukemia

All 140 drugs for Adult Acute Myeloid Leukemia

Coming up1

Changes1

Last 90 days

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Recruiting May 2027 Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Phase 1Completed 16 May 2011 Single and Multiple Ascending Dose Study of KRP-203 in Healthy Japanese Adults
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Mocravimod

Following is part of Solo: you see every change to Mocravimod the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in